Results 1-20 of 75
Issue DateTitleAuthor(s)TypeМp-cat.
2025Antimicrobial Prophylaxis in Elective Orthopaedic Surgical Procedures at the Tertiary Care Hospital: A Prospective Observational StudyKosić, Milica; Miljković, Branislava  ; Barišić, Vedrana; Vezmar-Kovačević, Sandra  ; Jovanović, Marija  ; Vučićević, Katarina  ; Kovačević, TijanaArticle
21aM21a
2025Uticaj anemije na koncentracije infliksimaba i ishode lečenja kod pacijenata sa inflamatornim bolestima crevaHomšek, Ana  ; Marković, Srđan  ; Jovanović, Marija  ; Svorcan, Petar  ; Vučićević, Katarina  Conference Paper
Mp. category will be shown later
2025Comparative in silico/in vitro analysis of pharmacokinetic profiles of BET inhibitorsKoravovic, Mladen D  ; Kovacevic, Milena M  ; Jovanovic, Marija N  ; Tasic, Gordana D  ; Mayasundari, Anand; Nishiguchi, Gisele; Markovic, Bojan D  ; Rankovic, Zoran; Savic, Vladimir  Article
23M23
2025Bleeding risk and drug interactions in patients with atrial fibrillation taking oral anticoagulantsKovačević, Milena  ; Vezmar-Kovačević, Sandra  ; Ćulafić, Milica  ; Jovanović, Marija  ; Vučićević, Katarina  ; Stevanović, Predrag  ; Radovanović, Slavica; Miljković, Branislava  Article
51M51
2025A Clinical Perspective of Therapeutic Drug Monitoring of Cyclosporine in Pediatric Patients with Kidney TransplantRoganović, Maša  ; Jovanović, Marija  ; Vučićević, Katarina  Article
51M51
2025Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal AnalysisMilašinović, Bojana  ; Vezmar-Kovačević, Sandra  ; Marković, Srđan  ; Jovanović, Marija  ; Knežević-Ivanovski, Tamara; Kralj, Ðorđe; Svorcan, Petar  ; Miljković, Branislava  ; Vučićević, Katarina  Article
21aM21a
2025Potential QT-prolonging drug-drug interactions in cardiovascular disease patientsKovačević, Milena  ; Ćulafić, Milica  ; Jovanović, Marija  ; Vezmar-Kovačević, Sandra  ; Vučićević, Katarina  ; Miljković, Branislava  ; Stevanović, Predrag  ; Radovanović, SlavicaArticle
23M23
2024Role of Pharmacists in the Management of Patients with ObesityJovanović, Marija  ; Kovačević, Milena  ; Ćulafić, Milica  Article
51M51
2024Potentially inappropriate prescribing in elderly patients across healthcare settings: application of STOPP/START version 2 criteriaKovačević, Milena  ; Catić-Đorđević, Aleksandra  ; Jovanović, Marija  ; Ćulafić, Milica  ; Stefanović, Nikola  ; Mitić, Branka  ; Vučićević, Katarina  ; Vezmar-Kovačević, Sandra  ; Veličković-Radovanović, Radmila  ; Miljković, Branislava  Article
22M22
2024Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignanciesŠkorić, Biljana; Jovanović, Marija  ; Kuzmanović, Miloš  ; Miljković, Branislava  ; Vučićević, Katarina  Article
22M22
2024Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical ApplicabilityJovanović, Marija  ; Homšek, Ana  ; Marković, Srđan; Kralj, Đorđe; Svorcan, Petar  ; Knežević Ivanovski, Tamara; Odanović, Olga; Vučićević, Katarina  Article
21M21
2024Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World PharmacokineticsMarković, Srđan  ; Kralj, Ðorđe; Svorcan, Petar  ; Knežević-Ivanovski, Tamara; Odanović, Olga; Obradović, Sanja; Homšek, Ana  ; Jovanović, Marija  ; Savić, Rada; Vučićević, Katarina  Article
21aM21a
2023Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncologyHomšek, Ana  ; Spasić, Jelena  ; Nikolić, Neda  ; Stanojković, Tatjana  ; Jovanović, Marija  ; Miljković, Branislava  ; Vučićević, Katarina  Article
23M23
2023Lidocaine Clearance as Pharmacokinetic Parameter of Metabolic Hepatic Activity in Patients with Impaired LiverJovanović, Marija  ; Kovačević, Milena  ; Vezmar-Kovačević, Sandra  ; Palibrk, Ivan; Bjelanović, Jasna; Miljković, Branislava  ; Vučićević, Katarina  Article
23M23
2023Modelling fatigue events in prostate cancer patients on radiotherapyRoganović, Maša  ; Stanojković, Tatjana  ; Nikitović, Marina  ; Petrović, Nina  ; Đurić, Ana  ; Matić, Ivana  ; Jovanović, Marija  ; Vučićević, Katarina  Conference Paper
Mp. category will be shown later
2023Association of clozapine and norclozapine levels with patient and therapy characteristics—focus on interaction with valproic acidPanić, Bojana; Jovanović, Marija  ; Lukić, Vera  ; Vučićević, Katarina  ; Miljković, Branislava  ; Milovanović, Srđan  Article
22M22
2023Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteriaJovanović, Marija  ; Kovačević, Milena  ; Catić-Đorđević, Aleksandra  ; Ćulafić, Milica  ; Stefanović, Nikola  ; Mitić, Branka  ; Vučićević, Katarina  ; Vezmar-Kovačević, Sandra  ; Veličković-Radovanović, Radmila  ; Miljković, Branislava  Article
23M23
2023Population pharmacokinetic model of infliximab in patients with fistulising Crohn’s diseaseHomšek, Ana  ; Marković, Srđan  ; Kralj, Đorđe; Odanović, Olga; Svorcan, Petar  ; Jovanović, Marija  ; Vučićević, Katarina  Conference Paper
Mp. category will be shown later
2023COVID-19 and Behavioral Factors of e-Payment Use: Evidence from SerbiaMilosavljević, Miloš  ; Okanović, Milan  ; Cicvarić Kostić, Slavica  ; Jovanović, Marija  ; Radonić, MilenkoArticle
21M21
2023Review of the Clinical Pharmacokinetics, Efficacy and Safety of PembrolizumabHomšek Ana  ; Radosavljević Davorin  ; Miletić Nebojša  ; Spasić Jelena  ; Jovanović Marija  ; Miljković Branislava  ; Stanojković Tatjana  ; Vučićević Katarina  Article
22M22